Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra M Swain

Showing results (11-20 of 210) with videos related to

Pageof 21
Sort By:
Journal of the National Cancer Institute|November 25, 2010
Meta-analysis: should it be more than the sum of its parts?Pia Herbolsheimer, Sandra M Swain
NPJ Breast Cancer|May 21, 2021
HER2-positive breast cancer and tyrosine kinase inhibitors: the time is nowIlana Schlam, Sandra M Swain
Expert Opinion on Drug Safety|March 17, 2016
Pertuzumab for the treatment of breast cancer: a safety reviewJennifer Gao, Sandra M Swain
Clinical Breast Cancer|December 15, 2010
CLEOPATRA: a phase III evaluation of pertuzumab and trastuzumab for HER2-positive metastatic breast cancerJosé Baselga, Sandra M Swain
Cancer|May 27, 2010
Primary systemic chemotherapy for inflammatory breast cancerSarah Sinclair, Sandra M Swain
Nature Reviews. Cancer|June 19, 2009
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3José Baselga, Sandra M Swain
Expert Opinion on Investigational Drugs|March 7, 2008
Ixabepilone for the treatment of solid tumors: a review of clinical dataNeelima Denduluri, Sandra M Swain
Expert Opinion on Pharmacotherapy|January 24, 2012
Avastin withdrawal symptomsFilipa Lynce, Sandra M Swain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Bevacizumab and heart failure risk in patients with breast cancer: a thorn in the side?Nitin Verma, Sandra M Swain
Oncology (Williston Park, N.Y.)|May 27, 2014
Pertuzumab: increasing the optionsRaquel Nunes, Sandra M Swain
Pageof 21

Showing results (11-20 of 210) with videos related to

Sort By:
Pageof 21
Journal of the National Cancer Institute|November 25, 2010
Meta-analysis: should it be more than the sum of its parts?Pia Herbolsheimer, Sandra M Swain
NPJ Breast Cancer|May 21, 2021
HER2-positive breast cancer and tyrosine kinase inhibitors: the time is nowIlana Schlam, Sandra M Swain
Expert Opinion on Drug Safety|March 17, 2016
Pertuzumab for the treatment of breast cancer: a safety reviewJennifer Gao, Sandra M Swain
Clinical Breast Cancer|December 15, 2010
CLEOPATRA: a phase III evaluation of pertuzumab and trastuzumab for HER2-positive metastatic breast cancerJosé Baselga, Sandra M Swain
Cancer|May 27, 2010
Primary systemic chemotherapy for inflammatory breast cancerSarah Sinclair, Sandra M Swain
Nature Reviews. Cancer|June 19, 2009
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3José Baselga, Sandra M Swain
Expert Opinion on Investigational Drugs|March 7, 2008
Ixabepilone for the treatment of solid tumors: a review of clinical dataNeelima Denduluri, Sandra M Swain
Expert Opinion on Pharmacotherapy|January 24, 2012
Avastin withdrawal symptomsFilipa Lynce, Sandra M Swain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Bevacizumab and heart failure risk in patients with breast cancer: a thorn in the side?Nitin Verma, Sandra M Swain
Oncology (Williston Park, N.Y.)|May 27, 2014
Pertuzumab: increasing the optionsRaquel Nunes, Sandra M Swain
Pageof 21